-
Prospective Databased of Clinical Outcomes Following Cryotherapy for ablation of clinically localized prostate cancer
The purpose of this study is to better understand how well Cryo Ablation treats prostate cancer and the long-term effects of this treatment of sexual ... -
A Parallel-Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1
If you have been diagnosed with advanced prostate cancer with high levels of DickkopM (DKK1), you may qualify for this Phase 1b/2a study investigating ...Phase
Interventional
-
Using a Geographically Targeted and Mixed Methods Approach to Improve Glycemic Control among Black Men Identified as Having Previously Undiagnosed Diabetes and Prediabetes
Poor sugar control, high rates of diabetes-related hospital use, and a high prevalence of microvascular diabetic complications all have shown to cluster in the same ... -
AbbVie Inc. Study M16-006
The purpose of this study is to evaluate the efficacy and safety of different doses of risankizumab and determine how well it works in managing ...Phase
Interventional
-
NYU Winthrop Hospital Minimally Invasive Treatment for BPH Database
The rationale and specific goal of this research is to build a database of patients undergoing the Urolift or Rezum procedure for benign prostatic hyperplasia ... -
NYU Cooperative Prostate Cancer Tissue Resource
The purpose of this study is to collect prostate tissue, blood, urine, and health information from a large group of patients for whom prostate cancer ... -
Sangamo Fabry disease gene therapy study (ST-920-201)
Fabry disease is caused by mutations in the GLA gene. The GLA gene encodes the lysosomal enzyme alpha-galactosidase A, or a-Gal A for short. When ...Phase
Interventional
-
Metformin Prostate Cancer Adjuvant Trial
The purpose of the study is to determine the safety and effectiveness of Metformin can increase Prostate Specific Antigen (PSA) doubling time for patients with ...Phase
Interventional
-
A Phase 1b/2 Open-Label Randomized Platform Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Castrate Resistant Prostate Cancer
The purpose of the study is to determine the safety and efficacy of the treatments: AB928, a novel adenosine receptor blocker, plus zimberelimab, an anti-PD1 ...Phase
Interventional
-
Phase 3 Randomized Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (KEYNOTE-991)
The purpose of the trial is to determine the safety and efficacy of the pembrolizumab plus enzalutamide plus ADT versus placebo plus enzalutamide plus androgen ...Phase
Interventional
